65
Views
4
CrossRef citations to date
0
Altmetric
Clinical Features

Next-Generation GLP-1 Therapy: An Introduction to Liraglutide

, DO, FACP, FACOI, FACE, CDE
Pages 239-247 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ajay Kumar. (2014) Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy. Expert Opinion on Biological Therapy 14:6, pages 869-878.
Read now

Articles from other publishers (3)

Lei Sun, Zhi-Ming Zheng, Chang-Sheng Shao, Zhi-Yong Zhang, Ming-Wei Li, Li Wang, Han Wang, Gen-Hai Zhao & Peng Wang. (2022) Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists. Pharmaceuticals 15:6, pages 740.
Crossref
Stewart Harris, Martin J. Abrahamson, Antonio Ceriello, Guillaume Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard I. G. Holt, Nóra Hosszúfalusi, Guy Rutten & Tina Vilsbøll. (2020) Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes. Drugs 80:2, pages 147-165.
Crossref
Chong Gao, Yueze Liu, Yuanhong Jiang, Jianming Ding & Lin Li. (2014) Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin-Induced Alzheimer Rat Model. Brain Pathology 24:3, pages 261-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.